Global Oncology Academy

New Approaches to Treating Non-Small Cell Lung Cancer

New Approaches to Treating Non-Small Cell Lung Cancer
RestartResume

How is the KEYNOTE-189 study changing the non-small cell lung cancer treatment landscape?

  • Overview

    Survival rates for patients with non-small cell lung cancer have notably improved thanks to the development of targeted therapies and immunotherapies. With these recent advancements on the forefront, Dr. Deepa Rangachari joins Dr. Jennifer Caudle to discuss the KEYNOTE-189 study and how it could change our approach to treating patients with non-small cell lung cancer.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free